Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oncology Therapeutics Network (OTN) was a leading specialty distributor and group purchasing organization (GPO) focused on the oncology market in the United States. Originally established as a division of Bristol Myers Squibb, the company provided community-based oncologists with access to a comprehensive portfolio of branded and generic chemotherapy drugs, supportive care products, and practice management services. OTN was particularly known for its generic drug program, which helped oncology practices manage costs while maintaining high standards of patient care. The company was acquired by McKesson in 2007 and subsequently integrated into McKesson Specialty Health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Otn Generics.